Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" thanks to its user-friendly and affordable design, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on October 1, 2024.
SAN DIEGO, CA / ACCESSWIRE / 2024年9月30日 / 模块医疗器械公司（纳斯达克: MODD）（“模块医疗”或“公司”），一家胰岛素输送技术公司，拥有首款专为目标所有成年“准泵用户”设计的FDA认证贴片泵，便于使用且价格实惠。 将参加Lytham Partners 2024年秋季投资者大会的网络直播演示，并与投资者进行一对一会议，大会将于2024年10月1日线上举行。
Company Webcast
公司网络研讨会
The Company's webcasted presentation will take place at 2:00 p.m. Eastern Time on Tuesday, October 1. The webcast can be accessed by visiting the conference home page at and will also be available for replay following the event.
公司的网络直播演示将于10月1日星期二美国东部时间下午2:00进行。 可通过访问会议主页进行观看，并将在活动结束后提供重播。
1×1 Meetings
一对一会议
Jeb Besser, the Company's Chief Executive Officer, will host virtual one-on-one meetings throughout the event. To arrange a meeting with Mr. Besser, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at .
公司首席执行官Jeb Besser将在活动期间主持虚拟一对一会议。 若要安排与Besser先生的会议，请联系Lytham Partners：1×1@lythampartners.com或注册参加活动。
About Modular Medical
关于医疗模块化公司
Modular Medical, Inc. (Nasdaq: MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Modular Medical's mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
模块医疗器械公司（纳斯达克: MODD）是一家医疗器械公司，旨在推出下一代胰岛素输送技术。公司利用其专利技术，力求消除复杂性和效力之间的折衷，从而使高质量的胰岛素输送既经济又简单易学。 模块医疗的使命是为糖尿病患者改善葡萄糖控制的最高标准，超越“超级用户”，为“我们中其他人”提供“糖尿病护理”。
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at .
Modular Medical由经验丰富的医疗器械专业人士和微流控工程师Paul DiPerna创立。在创立Modular Medical之前，DiPerna先生是Tandem Diabetes的创始人（2005年）并发明和设计了其t：slim胰岛素泵。请访问以获取更多信息。
All trademarks mentioned herein are the property of their respective owners.
这里提到的所有商标均为其各自所有者的财产。
CONTACT:
联系人：
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
Jeb Besser
首席执行官
医疗模块化公司
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
来源：Modular Medical, Inc。